Elevated MIA serum levels are of relevance for management of metastasized malignant melanomas: results of a German multicenter study.
暂无分享,去创建一个
A. Hauschild | D. Schadendorf | W. Stolz | A. Bosserhoff | M. Landthaler | R. Buettner | E. Stockfleth | R. Hein | T. Bogenrieder | Wilhelm Stolz | Eggert Stockfleth | Axel Hauschild | D. Schadendorf | M. Landthaler | A. Bosserhoff | Rüdiger Hein | Reinhard Buettner | Thomas Bogenrieder
[1] W. Stolz,et al. MIA, a novel serum marker for progression of malignant melanoma. , 1999, Anticancer research.
[2] W. Stolz,et al. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. , 1997, Cancer research.
[3] A. Bosserhoff,et al. Assignment of the human melanoma inhibitory activity gene (MIA) to 19q13.32-q13.33 by fluorescence in situ hybridization (FISH). , 1996, Genomics.
[4] A. Bosserhoff,et al. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. , 1994, Cancer research.
[5] A. Bosserhoff,et al. Melanoma-inhibitory activity protein concentrations in blood of melanoma patients treated with immunotherapy. , 1999, Oncology research.